(Date:10/13/2008)... come with other NSAID pain relievers, experts say...- When the pain killer Vioxx was pulled from the m...he risk of heart attack, stroke and death -- many ... , But a new study finds that "the risk was in...or approximately a year," said co-author Dr. Rober...
(Date:10/13/2008)...sored stop-smoking programs for inpatients that in...th significantly improve patients, ability to stay...ograms offered at hospitals around the world finds...ease participant,s chances of success by 65 percen...the Tobacco Research and Treatment Center at Massa...
(Date:10/13/2008)...udy suggests that the combination of low plasma le...the sun is associated with certain forms of the ey...according to a report in the October issue of Arc... journals. , "The retina is vulnerable to the d...ckground information in the article. "While wavele...
(Date:10/13/2008)...d smoking cessation programs, along with referrals...d with increased rates of quitting smoking followi... 13, 2008, issue of Archives of Internal Medicine...iversity researchers studied 639 patients who smok...attack. Six months later, 297 of the patients app...
Breaking Medicine News(10 mins):Health News:Vioxx's Heart Risk Lingered Long After Use Ended 2Health News:Vioxx's Heart Risk Lingered Long After Use Ended 3Health News:Intensive support programs can help hospitalized smokers stay smoke-free 2Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2...g technique for prostate cancers has been found ou...e traditional examination. In the traditional exam...samples from the prostate gland. At Ohio State U...at it is better to take more samples. Dr.Robert Ba...
...in helping people deal with stress. There has been... helps people improve both their physical and ment...versity in the US have been looking at how a medit...aining' can help people who describe themselves as...
...lly indicated by itchy flaky scalp to give it a m...u can treat dandruff by using a medicated shampoo,... from time to time, as individual products may los...th the shampoo every day or so, and make sure it a...
...rket with an advertising blitz--but no proof it wo...seasonal allergies, one tiny blue pill," proclaim ...ring-Plough makes Claritin, the nation's best-sell...mber, the Food and Drug Administration is expected...
Other Medicine News:(Date:10/13/2008)... Expansion of Genomic DNA from Multiple Cancer... Disease Studies, ANN ARBOR, Mich., Oct. 13 /PRN... an agreement with SAIC-Frederick to amplify DNA s...con Genomics was selected to amplify and standardi...amples from cancer patients. The Rubicon,GenomePle...
(Date:10/10/2008)... WASHINGTON and MENLO PARK, Calif., Oct. 10 /...T ) today announced that it plans to present,long-...clinical trials next,week at the Cardiovascular Re...theter Cardiovascular Therapeutics (TCT) meeting i...rospective studies designed to investigate,the saf...
(Date:10/10/2008)... PLEASANTON, Calif., Oct. 10 /- ... has been authorized to affix the CE (Conformite,E... Antares(TM) Coronary,Stent System, a unique main ...or near coronary bifurcations., Representing the ...es(TM) system has potential use in a quarter of th...
(Date:10/9/2008)... Scripps Translational Science Institute, Nav...eaking health study, SAN DIEGO, Oct. 9 /PRNewswir...research leaders have joined forces in a first-of-...mpact of personal genetic testing,on people who ch...potential,risk for developing certain diseases., ...
Breaking Medicine Technology:Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5FDA Panel to Consider Over the Counter Statin 8183 1FDA Panel to Consider Over the Counter Statin 8183 2FDA Panel to Consider Over the Counter Statin 8183 3FDA Panel to Consider Over the Counter Statin 8183 4FDA Panel to Consider Over the Counter Statin 8183 5BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends 8181 1BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends 8181 2Shire plc 3A Board Changes 2173 1Shire plc 3A Board Changes 2173 2Shire plc 3A Board Changes 2173 3Shire plc 3A Board Changes 2173 4Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update 2170 1...is Examines Impact of Pain on Sleep Interference, ...-- Data from a,pooled analysis of three studies su...c nerve damage, or diabetic peripheral neuropathy,...mprovements in,both average daily pain and night p...d sleep interference than in those patients,taking...
...ay 03, 2007 /PRNewswire/ -- Bayer HealthCare,Pharm...inical,studies with Betaseron(R) (interferon beta-...f Neurology,s (AAN) 59th Annual Meeting,demonstra...igh,patient satisfaction with treatment in patient... , "Collectively, these studies highlight the impo...
Other Medicine Technology:Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: